• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含羧酰胺的曲马普瑞林类似物的合成作为 LSD1(KDM1A)抑制剂,针对急性髓细胞白血病。

Synthesis of Carboxamide-Containing Tranylcypromine Analogues as LSD1 (KDM1A) Inhibitors Targeting Acute Myeloid Leukemia.

机构信息

School of Pharmacy, University of East Anglia, Norwich, NR4 7TJ, UK.

Norwich Medical School, University of East Anglia, Norwich, NR4 7TJ, UK.

出版信息

ChemMedChem. 2021 Apr 20;16(8):1316-1324. doi: 10.1002/cmdc.202000754. Epub 2021 Feb 3.

DOI:10.1002/cmdc.202000754
PMID:33533576
Abstract

Lysine-specific demethylase 1 (LSD1/KDM1A) oxidatively removes methyl groups from histone proteins, and its aberrant activity has been correlated with cancers including acute myeloid leukemia (AML). We report a novel series of tranylcypromine analogues with a carboxamide at the 4-position of the aryl ring. These compounds, such as 5 a and 5 b with benzyl and phenethylamide substituents, respectively, had potent sub-micromolar IC values for the inhibition of LSD1 as well as cell proliferation in a panel of AML cell lines. The dose-dependent increase in cellular expression levels of H3K4me2, CD86, CD11b and CD14 supported a mechanism involving LSD1 inhibition. The tert-butyl and ethyl carbamate derivatives of these tranylcypromines, although inactive in LSD1 inhibition, were of similar potency in cell-based assays with a more rapid onset of action. This suggests that carbamates can act as metabolically labile tranylcypromine prodrugs with superior pharmacokinetics.

摘要

赖氨酸特异性脱甲基酶 1(LSD1/KDM1A)氧化去除组蛋白上的甲基,其异常活性与包括急性髓细胞性白血病(AML)在内的多种癌症相关。我们报告了一系列新型反苯环丙胺类似物,其芳环的 4 位带有酰胺基。这些化合物,如分别带有苄基和苯乙酰胺取代基的 5a 和 5b,对 LSD1 的抑制作用以及一系列 AML 细胞系的细胞增殖具有强效的亚微摩尔 IC 值。细胞内 H3K4me2、CD86、CD11b 和 CD14 的表达水平呈剂量依赖性增加,支持 LSD1 抑制的作用机制。这些反苯环丙胺的叔丁基和乙基氨基甲酸酯衍生物尽管在 LSD1 抑制方面没有活性,但在基于细胞的测定中具有相似的效力,且作用更快。这表明氨基甲酸酯可以作为代谢不稳定的反苯环丙胺前药,具有更好的药代动力学特性。

相似文献

1
Synthesis of Carboxamide-Containing Tranylcypromine Analogues as LSD1 (KDM1A) Inhibitors Targeting Acute Myeloid Leukemia.含羧酰胺的曲马普瑞林类似物的合成作为 LSD1(KDM1A)抑制剂,针对急性髓细胞白血病。
ChemMedChem. 2021 Apr 20;16(8):1316-1324. doi: 10.1002/cmdc.202000754. Epub 2021 Feb 3.
2
Fluorinated tranylcypromine analogues as inhibitors of lysine-specific demethylase 1 (LSD1, KDM1A).氟化反苯环丙胺类似物作为赖氨酸特异性去甲基化酶1(LSD1,KDM1A)的抑制剂
Bioorg Med Chem Lett. 2017 May 15;27(10):2099-2101. doi: 10.1016/j.bmcl.2017.03.081. Epub 2017 Mar 29.
3
New tranylcypromine derivatives containing sulfonamide motif as potent LSD1 inhibitors to target acute myeloid leukemia: Design, synthesis and biological evaluation.新型含磺酰胺基的曲马朵衍生物作为潜在的 LSD1 抑制剂用于治疗急性髓系白血病:设计、合成与生物学评价。
Bioorg Chem. 2020 Jun;99:103808. doi: 10.1016/j.bioorg.2020.103808. Epub 2020 Apr 17.
4
Enantioselective synthesis of tranylcypromine analogues as lysine demethylase (LSD1) inhibitors.手性合成反式环丙胺类似物作为赖氨酸去甲基酶(LSD1)抑制剂。
Bioorg Med Chem. 2011 Jun 15;19(12):3709-16. doi: 10.1016/j.bmc.2011.02.017. Epub 2011 Feb 13.
5
Discovery of novel tranylcypromine-indazole-based derivatives as LSD1 inhibitors for acute myeloid leukemia treatment.发现新型反苯环丙胺-吲唑基衍生物作为用于急性髓系白血病治疗的赖氨酸特异性去甲基化酶1(LSD1)抑制剂。
Eur J Med Chem. 2025 May 5;289:117438. doi: 10.1016/j.ejmech.2025.117438. Epub 2025 Feb 23.
6
Novel potent inhibitors of the histone demethylase KDM1A (LSD1), orally active in a murine promyelocitic leukemia model.组蛋白去甲基化酶KDM1A(LSD1)的新型强效抑制剂,在小鼠早幼粒细胞白血病模型中具有口服活性。
Future Med Chem. 2017 Jul;9(11):1161-1174. doi: 10.4155/fmc-2017-0003. Epub 2017 Jul 19.
7
Structure-activity studies on N-Substituted tranylcypromine derivatives lead to selective inhibitors of lysine specific demethylase 1 (LSD1) and potent inducers of leukemic cell differentiation.对N-取代反苯环丙胺衍生物的构效关系研究产生了赖氨酸特异性去甲基化酶1(LSD1)的选择性抑制剂以及白血病细胞分化的强效诱导剂。
Eur J Med Chem. 2018 Jan 20;144:52-67. doi: 10.1016/j.ejmech.2017.12.001. Epub 2017 Dec 6.
8
Tranylcypromine-Based LSD1 Inhibitors: Structure-Activity Relationships, Antiproliferative Effects in Leukemia, and Gene Target Modulation.基于曲尼司特的 LSD1 抑制剂:结构-活性关系、白血病中的抗增殖作用和基因靶标调节。
ChemMedChem. 2020 Apr 3;15(7):643-658. doi: 10.1002/cmdc.201900730. Epub 2020 Feb 14.
9
Tying up tranylcypromine: Novel selective histone lysine specific demethylase 1 (LSD1) inhibitors.抑制反苯环丙胺:新型选择性组蛋白赖氨酸特异性去甲基化酶1(LSD1)抑制剂
Eur J Med Chem. 2017 Dec 1;141:101-112. doi: 10.1016/j.ejmech.2017.09.073. Epub 2017 Oct 3.
10
Heterocycle-containing tranylcypromine derivatives endowed with high anti-LSD1 activity.含杂环的曲马普汀衍生物具有高 LSD1 抑制活性。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):973-985. doi: 10.1080/14756366.2022.2052869.

引用本文的文献

1
Synthetic and structure-activity studies of SP2577 and TCP towards LSD1 targeting PROTACs.针对靶向LSD1的PROTAC的SP2577和TCP的合成及构效关系研究。
RSC Med Chem. 2025 Aug 5. doi: 10.1039/d5md00420a.
2
Induction of AML cell differentiation using HOXA9/DNA binding inhibitors as a potential therapeutic option for HOXA9-dependent AML.使用HOXA9/DNA结合抑制剂诱导AML细胞分化作为HOXA9依赖性AML的一种潜在治疗选择。
Hemasphere. 2024 May 6;8(5):e77. doi: 10.1002/hem3.77. eCollection 2024 May.
3
LSD1 inhibitors for cancer treatment: Focus on multi-target agents and compounds in clinical trials.
用于癌症治疗的 LSD1 抑制剂:聚焦于多靶点药物及临床试验中的化合物。
Front Pharmacol. 2023 Feb 2;14:1120911. doi: 10.3389/fphar.2023.1120911. eCollection 2023.